Herbert Smith Freehills Advises on Arena REIT IPO

Herbert Smith Freehills is advising Morgan Stanley and National Australia Bank as joint lead managers and underwriters for Arena REIT’s initial public offering and listing on the Australian Securities Exchange. Arena REIT is one of Australia’s largest owners of child care properties, holding a portfolio valued at over $220 million. It will raise $75 million of new money under the IPO.

More >>

Tags:  Herbert Smith Freehills Kramer LLP

Herbert Smith Freehills Advises Joint Lead Managers on Macquarie’s A$400 Million Capital Notes Issue

Herbert Smith Freehills has advised the Joint Lead Managers of Macquarie Group Limited’s (MGL) offer of new Tier 1 hybrid securities known as Macquarie Capital Notes (MCN), which are fully paid, subordinated, non-cumulative, unsecured, mandatorily convertible notes issued by MGL. The offer is intended to raise $400 million, with the ability to raise more or less.

More >>

Tags:  Herbert Smith Freehills Kramer LLP

Discovery Duo Find Drinker Biddle

Bennett B. Borden and Jay Brudz joined Drinker Biddle & Reath LLP today as partners in the firm’s Washington, D.C., office. They will chair Drinker’s Information Governance and Electronic Discovery practice as well as help oversee the firm’s ediscovery subsidiary, Drinker Discovery Solutions. They served as co-chairs of the Electronic Discovery and Information Governance Section of their previous firm, Williams Mullen.

More >>

Tags:  Drinker Biddle & Reath, LLP

Cadwalader Advises Elan Corporation in Billion Dollar Royalty Deal

Cadwalader, Wickersham & Taft LLP, a leading counselor to global financial institutions and corporations, announced today that client Elan Corporation, plc, a biotechnology company headquartered in Ireland, will purchase from Theravance, Inc. a 21% participation interest in potential future royalty payments related to four respiratory programs partnered with GlaxoSmithKline plc: RELVAR™ ELLIPTA™/BREO™ ELLIPTA™, AORO™ ELLIPTA™, MABA (Bifunctional Muscarinic Antagonist-Beta2 Agonist) monotherapy (GSK961081) and vilanterol (VI) monotherapy. In exchange for the participation interest, Elan will make a one-time cash payment to Theravance of $1.0 billion.

More >>

Tags:  Cadwalader, Wickersham & Taft LLP | New York

K&L Gates Advises Nabil Foods Founding Family on Strategic Partnership with The Carlyle Group

A Dubai-based team of lawyers from global law firm K&L Gates LLP has advised Jordan’s Rassam family on the sale of a significant minority interest in Al Nabil Food Industries Limited Company (“Nabil Foods”) to global alternative asset manager, The Carlyle Group (NASDAQ:CG). The transaction closed on May 13, 2013, and is the first significant investment by an international private equity house into Jordan.

More >>

Tags:  K&L Gates LLP | Dubai

Davis Polk Advises CITIC Capital Partners on Its Acquisition of AsiaInfo-Linkage

Davis Polk is advising CITIC Capital Partners in connection with the $890 million going-private acquisition of Nasdaq-listed AsiaInfo-Linkage, Inc. by a consortium led by CITIC Capital Partners and that includes Edward Tian, a co-founder and significant stockholder of AsiaInfo-Linkage. The acquisition is subject to customary closing conditions, including receipt of required regulatory approvals and approval by AsiaInfo-Linkage’s stockholders.

More >>

Tags:  Davis Polk & Wardwell LLP | Hong Kong